Sign Up to like & get
recommendations!
1
Published in 2017 at "Value in Health"
DOI: 10.1016/j.jval.2017.08.387
Abstract: Background and objectives • In today’s economically constrained environment, payers have responded to the potentially high cost of new oncology medicines by conducting value-for-money assessments through national or regional pricing and reimbursement (P&R) and health…
read more here.
Keywords:
countries similar;
gdps health;
similar gdps;
expenditures reimburse ... See more keywords